AJP - GI Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (July 19, 2007). doi:10.1152/ajpgi.00185.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/G631    most recent
00185.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Son, G.
Right arrow Articles by Fujimoto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Son, G.
Right arrow Articles by Fujimoto, J.
Submitted on April 27, 2007
Accepted on July 13, 2007

Selective inactivation of NF-{kappa}B in the liver using NF-{kappa}B decoy suppresses CCl4-induced liver injury and fibrosis

Gakuhei Son1, Yuji Iimuro1, Ekihiro Seki1, Tadamichi Hirano1, Yasufumi Kaneda2, and Jiro Fujimoto3*

1 Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
2 Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
3 First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan

* To whom correspondence should be addressed. E-mail: sfujimo{at}hyo-med.ac.jp.

Sustained hepatic inflammation induced by various causes can lead to liver fibrosis. Transcription factor NF-{kappa}B is important in regulating inflammatory responses, especially in macrophages. We presently investigated whether an NF-{kappa}B decoy, a synthetic oligodeoxynucleotide (ODN) imitating the NF-{kappa}B binding site, inhibited the inflammatory response after CCl4 intoxication to prevent CCl4-induced hepatic injury and fibrosis. The NF-{kappa}B decoy was introduced into livers by injecting the spleens of mice, using a hemagglutinating virus of Japan (HVJ)-liposome method. ODN was transferred mainly to macrophages in normal or fibrotic livers. Increases in serum transaminases and production of inflammatory cytokines after a single challenge with CCl4 were inhibited by the NF-{kappa}B decoy, which suppressed nuclear translocation of NF-{kappa}B in liver macrophages. Liver fibrosis induced by CCl4 administration for 8 weeks was suppressed by the NF-{kappa}B decoy, accompanied by diminished mRNA expression for transforming growth factor (TGF)-{beta}1, procollagen type1 {alpha}1, and {alpha}-smooth muscle actin (SMA). In vitro, isolated liver macrophages showed increased DNA binding activity of NF-{kappa}B and inflammatory cytokine production after hydrogen peroxide treatment; both increases were inhibited significantly by the NF-{kappa}B decoy. In contrast, NF-{kappa}B decoy transferred to isolated hepatic stellate cells (HSC) had no effect on their morphologic activation or {alpha}-SMA expression, although the decoy accelerated tumor necrosis factor (TNF) {alpha}-induced apoptosis in activated HSC. The effect of NF-{kappa}B decoy suppressing fibrosis probably results mainly from anti-inflammatory effects on liver macrophages, with a possible minor contribution from its direct pro-apoptotic effect on activated HSC.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.